-
公开(公告)号:EP2863936A1
公开(公告)日:2015-04-29
申请号:EP13787673.6
申请日:2013-03-11
申请人: MedImmune, LLC , Medimmune Limited
发明人: MINTER, Ralph , DOUTHWAITE, Julie , MOISAN, Jacques , BOWEN, Michael , RUST, Steve , PRIVEZENTZEV, Cyril
CPC分类号: C07K14/70521 , A61K38/00 , C07K2319/30
摘要: Variants of cytotoxic T-lymphocyte antigen 4 (CTLA-4) with high affinity, potency and stability. Formulations of CTLA-4 variants at high concentration for subcutaneous or intravenous administration, e.g. at monthly or less frequent dosage intervals. Use of CTLA-4 variants for treating rheumatoid arthritis and other inflammatory disorders. Fusion of CTLA-4 with IgG Fc having improved stability and longer in vivo half-life.